David Hipkiss

David Hipkiss

Président chez
AlveoGene Ltd.
56 ans
Process Industries
Health Technology
Finance

Profil

David John Hipkiss was the founder of Prosonix Ltd. which was founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2012.
He is currently the Chairman of AlveoGene Ltd. since 2023.
Mr. Hipkiss's former jobs include being the Chief Executive Officer & Director of Enesi Pharma Ltd., a Principal at Air Products & Chemicals, Inc. and The Dow Chemical Co., the General Manager of Accentus LLC and Accentus Medical Ltd., a Principal at Chirotech Technology Ltd. and Ascot Plc, and the Chief Business Officer of Niox Group Plc.
Mr. Hipkiss received an undergraduate degree from the University of Birmingham.

Postes actifs de David Hipkiss

SociétésPosteDébut
Président 01/07/2023

Anciens postes connus de David Hipkiss

SociétésPosteFin
Corporate Officer/Principal -
Directeur Général 01/07/2022
Ascot Plc
Corporate Officer/Principal -
NIOX GROUP PLC Corporate Officer/Principal -
AIR PRODUCTS & CHEMICALS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de David Hipkiss

Formation de David Hipkiss

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

4

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Process Industries

Process Industries

Technology Services

Consumer Services

Distribution Services

Health Technology

Finance

Ascot Plc

Health Services

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. David Hipkiss
🔇